Annual Working Capital
$69.77 M
-$30.55 M-30.45%
December 31, 2023
Summary
- As of February 8, 2025, ATNM annual working capital is $69.77 million, with the most recent change of -$30.55 million (-30.45%) on December 31, 2023.
- During the last 3 years, ATNM annual working capital has risen by +$9.61 million (+15.98%).
- ATNM annual working capital is now -30.45% below its all-time high of $100.31 million, reached on December 31, 2022.
Performance
ATNM Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$71.77 M
-$5.58 M-7.21%
September 30, 2024
Summary
- As of February 8, 2025, ATNM quarterly working capital is $71.77 million, with the most recent change of -$5.58 million (-7.21%) on September 30, 2024.
- Over the past year, ATNM quarterly working capital has increased by +$2.00 million (+2.86%).
- ATNM quarterly working capital is now -35.93% below its all-time high of $112.02 million, reached on June 30, 2022.
Performance
ATNM Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ATNM Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.4% | +2.9% |
| 3 y3 years | +16.0% | -9.2% |
| 5 y5 years | +744.0% | +696.5% |
ATNM Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.4% | at low | -35.9% | +5.0% |
| 5 y | 5-year | -30.4% | +1370.7% | -35.9% | +3323.9% |
| alltime | all time | -30.4% | +3446.4% | -35.9% | +632.3% |
Actinium Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $71.77 M(-7.2%) |
| Jun 2024 | - | $77.34 M(+0.0%) |
| Mar 2024 | - | $77.31 M(+10.8%) |
| Dec 2023 | $69.77 M(-30.4%) | $69.77 M(-9.3%) |
| Sep 2023 | - | $76.92 M(-11.0%) |
| Jun 2023 | - | $86.39 M(-4.7%) |
| Mar 2023 | - | $90.68 M(-9.6%) |
| Dec 2022 | $100.31 M(+37.6%) | $100.31 M(-4.5%) |
| Sep 2022 | - | $105.07 M(-6.2%) |
| Jun 2022 | - | $112.02 M(+63.9%) |
| Mar 2022 | - | $68.33 M(-6.3%) |
| Dec 2021 | $72.91 M(+21.2%) | $72.91 M(-7.8%) |
| Sep 2021 | - | $79.07 M(-0.3%) |
| Jun 2021 | - | $79.30 M(+14.0%) |
| Mar 2021 | - | $69.58 M(+15.7%) |
| Dec 2020 | $60.16 M(+1168.1%) | $60.16 M(+35.2%) |
| Sep 2020 | - | $44.50 M(-10.7%) |
| Jun 2020 | - | $49.85 M(+2278.4%) |
| Mar 2020 | - | $2.10 M(-55.8%) |
| Dec 2019 | $4.74 M(-42.6%) | $4.74 M(-47.3%) |
| Sep 2019 | - | $9.01 M(-39.0%) |
| Jun 2019 | - | $14.77 M(+234.9%) |
| Mar 2019 | - | $4.41 M(-46.7%) |
| Dec 2018 | $8.27 M(-37.2%) | $8.27 M(-25.1%) |
| Sep 2018 | - | $11.03 M(-34.4%) |
| Jun 2018 | - | $16.82 M(-20.9%) |
| Mar 2018 | - | $21.25 M(+61.3%) |
| Dec 2017 | $13.17 M(-26.3%) | $13.17 M(-25.5%) |
| Sep 2017 | - | $17.69 M(+111.6%) |
| Jun 2017 | - | $8.36 M(-34.4%) |
| Mar 2017 | - | $12.75 M(-28.7%) |
| Dec 2016 | $17.87 M(-18.3%) | $17.87 M(+26.8%) |
| Sep 2016 | - | $14.09 M(-25.5%) |
| Jun 2016 | - | $18.92 M(-4.9%) |
| Mar 2016 | - | $19.89 M(-9.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $21.87 M(-1148.9%) | $21.87 M(-3.9%) |
| Sep 2015 | - | $22.76 M(-1.7%) |
| Jun 2015 | - | $23.16 M(+42.0%) |
| Mar 2015 | - | $16.31 M(-882.2%) |
| Dec 2014 | -$2.08 M(+32.5%) | -$2.08 M(-194.9%) |
| Sep 2014 | - | $2.20 M(-47.2%) |
| Jun 2014 | - | $4.16 M(-130.9%) |
| Mar 2014 | - | -$13.48 M(+756.9%) |
| Dec 2013 | -$1.57 M(-237.7%) | -$1.57 M(-363.4%) |
| Sep 2013 | - | $597.40 K(-68.8%) |
| Jun 2013 | - | $1.91 M(+247.7%) |
| Mar 2013 | - | $550.80 K(-51.8%) |
| Dec 2012 | $1.14 M(+15.3%) | $1.14 M(-3774.0%) |
| Sep 2012 | - | -$31.10 K(+6.9%) |
| Jun 2012 | - | -$29.10 K(-2.3%) |
| Mar 2012 | - | -$29.80 K(-103.0%) |
| Dec 2011 | $990.80 K(-2852.2%) | $990.80 K(-3638.6%) |
| Sep 2011 | - | -$28.00 K(+14.3%) |
| Jun 2011 | - | -$24.50 K(-31.6%) |
| Mar 2011 | - | -$35.80 K(-0.6%) |
| Dec 2010 | -$36.00 K(+29.5%) | -$36.00 K(+10.8%) |
| Sep 2010 | - | -$32.50 K(+3150.0%) |
| Jun 2010 | - | -$1000.00(-96.8%) |
| Mar 2010 | - | -$31.60 K(+13.7%) |
| Dec 2009 | -$27.80 K(+14.9%) | -$27.80 K(+29.3%) |
| Sep 2009 | - | -$21.50 K(-5.3%) |
| Jun 2009 | - | -$22.70 K(+18.2%) |
| Mar 2009 | - | -$19.20 K(-20.7%) |
| Dec 2008 | -$24.20 K(+255.9%) | -$24.20 K(+23.5%) |
| Sep 2008 | - | -$19.60 K(-6.7%) |
| Jun 2008 | - | -$21.00 K(+44.8%) |
| Mar 2008 | - | -$14.50 K(+113.2%) |
| Dec 2007 | -$6800.00(+74.4%) | -$6800.00(-334.5%) |
| Sep 2007 | - | $2900.00(-323.1%) |
| Jun 2007 | - | -$1300.00(-66.7%) |
| Dec 2006 | -$3900.00 | -$3900.00 |
FAQ
- What is Actinium Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals annual working capital year-on-year change?
- What is Actinium Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals quarterly working capital year-on-year change?
What is Actinium Pharmaceuticals annual working capital?
The current annual working capital of ATNM is $69.77 M
What is the all time high annual working capital for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high annual working capital is $100.31 M
What is Actinium Pharmaceuticals annual working capital year-on-year change?
Over the past year, ATNM annual working capital has changed by -$30.55 M (-30.45%)
What is Actinium Pharmaceuticals quarterly working capital?
The current quarterly working capital of ATNM is $71.77 M
What is the all time high quarterly working capital for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high quarterly working capital is $112.02 M
What is Actinium Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, ATNM quarterly working capital has changed by +$2.00 M (+2.86%)